BiotechTube
Home/Valcare Medical/Omer Ostro
OO

Omer Ostro

CFO

Valcare Medical

Therapeutic Areas

CardiovascularStructural Heart Disease

Valcare Medical Pipeline

DrugIndicationPhase
AMEND™ Annuloplasty RingMitral RegurgitationEarly Feasibility
AMEND™ Transseptal Delivery SystemMitral RegurgitationEarly Feasibility

Leadership Team at Valcare Medical

SS
Steve Sandweg
CEO
NY
Nadav Yellin
General Manager
View full Valcare Medical profile